Display options
Cite
Sohn IS, Kim CJ, Oh BH, et al. Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial. Am J Cardiovasc Drugs. 2016;16(2):139doi: 10.1007/s40256-016-0167-2.
Sohn, I. S., Kim, C. J., Oh, B. H., Hong, T. J., Park, C. G., Kim, B. S., Chung, W. B. (2016). Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial. American journal of cardiovascular drugs : drugs, devices, and other interventions, 16(2), 139. https://doi.org/10.1007/s40256-016-0167-2
Sohn, Il Suk, et al. "Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial." American journal of cardiovascular drugs : drugs, devices, and other interventions vol. 16,2 (2016): 139. doi: https://doi.org/10.1007/s40256-016-0167-2
Sohn IS, Kim CJ, Oh BH, Hong TJ, Park CG, Kim BS, Chung WB. Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial. Am J Cardiovasc Drugs. 2016 Apr;16(2):139. doi: 10.1007/s40256-016-0167-2. PMID: 26994003; PMCID: PMC4969791.
Copy Download .nbib Format: NLM
Share it on

Am J Cardiovasc Drugs. 2016 Apr;16(2):139. doi: 10.1007/s40256-016-0167-2.

Erratum to: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial.

American journal of cardiovascular drugs : drugs, devices, and other interventions

Il Suk Sohn, Chong-Jin Kim, Byung-Hee Oh, Taek-Jong Hong, Chang-Gyu Park, Byung-Soo Kim, Woo-Baek Chung,

Affiliations

  1. Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea.
  2. Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, 101 Daehak-ro(28 Yongondong), Jongno-gu, Seoul, 110-744, Republic of Korea. [email protected].
  3. Pusan National University Hospital, Busan, Republic of Korea.
  4. Korea University Guro Hospital, Seoul, Republic of Korea.
  5. Daedong Hospital, Busan, Republic of Korea.
  6. Yeouido St. Mary's Hospital of the Catholic University of Korea, Seoul, Republic of Korea.

PMID: 26994003 PMCID: PMC4969791 DOI: 10.1007/s40256-016-0167-2

[No abstract available.]

Publication Types